Phase III clinical trial - Prostate

PRESTO (GETUG-AFU 36)
Prostate
Ouvert depuis le: 09.19.2021
Site: Paris
Public cible
Adulte
Prostate-cancer treatment using stereotactic radiotherapy for oligometastases;ablation in hormone-sensitive patients À a GETUG-AFU phase III randomized controlled trial
Description de l'essai

To assess the efficacy of ablative radiotherapy (SBRT applied to all;oligometastases) administered to all gross tumor sites (metastases +/- prostate), in oligometastatic;hormone-sensitive prostate cancer patients.